Literature DB >> 18685013

Comparison of two rapid human immunodeficiency virus (HIV) assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for detection of recent HIV seroconversion.

Rachana Kshatriya1, Ada A Cachafeiro, Ryan J S Kerr, Julie A E Nelson, Susan A Fiscus.   

Abstract

Modified protocols of two rapid tests were compared with a less sensitive (LS) (detuned) enzyme immunoassay (EIA) for their abilities to distinguish recent human immunodeficiency virus (HIV) seroconversion from long-term infections. The results for samples from 100 HIV-positive patient that had previously been tested by the Vironostika LS EIA had a 97% concordance with the results of the Determine HIV 1/2 assay and 93% concordance with those of the OraQuick HIV 1/2 assay.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18685013      PMCID： PMC2566129          DOI： 10.1128/JCM.00665-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Detuned assay used to track recent infections.

Authors:  L Highleyman
Journal:  BETA       Date:  1999

2.  Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast.

Authors:  S Koblavi-Dème; C Maurice; D Yavo; T S Sibailly; K N'guessan; Y Kamelan-Tano; S Z Wiktor; T H Roels; T Chorba; J N Nkengasong
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion.

Authors:  Stephen D Soroka; Timothy C Granade; Debra Candal; Bharat S Parekh
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Epidemiology of HIV/AIDS--United States, 1981-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-02       Impact factor: 17.586

5.  Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Authors:  Bhupat D Rawal; Azucena Degula; Ludmila Lebedeva; Robert S Janssen; Frederick M Hecht; Haynes W Sheppard; Michael P Busch
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

6.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272
  6 in total
  10 in total

1.  The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Authors:  Christine M Hogan; Victor Degruttola; Xin Sun; Susan A Fiscus; Carlos Del Rio; C Bradley Hare; Martin Markowitz; Elizabeth Connick; Bernard Macatangay; Karen T Tashima; Beatrice Kallungal; Rob Camp; Tia Morton; Eric S Daar; Susan Little
Journal:  J Infect Dis       Date:  2011-12-15       Impact factor: 5.226

2.  Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants.

Authors:  Anjuli D Wagner; Irene N Njuguna; Ruth A Andere; Lisa M Cranmer; Helen M Okinyi; Sarah Benki-Nugent; Bhavna H Chohan; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

3.  Rapid HIV testing program implementation: lessons from the emergency department.

Authors:  Christian Arbelaez; Brian Block; Elena Losina; Elizabeth A Wright; William M Reichmann; Regina Mikulinsky; Jessica D Solomon; Matthew M Dooley; Rochelle P Walensky
Journal:  Int J Emerg Med       Date:  2009-09-01

Review 4.  Current and future assays for identifying recent HIV infections at the population level.

Authors:  Joanna Smoleń-Dzirba; Tomasz J Wąsik
Journal:  Med Sci Monit       Date:  2011-05

5.  Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia.

Authors:  Dalila Zachary; Lawrence Mwenge; Monde Muyoyeta; Kwame Shanaube; Albertus Schaap; Virginia Bond; Barry Kosloff; Petra de Haas; Helen Ayles
Journal:  BMC Infect Dis       Date:  2012-08-08       Impact factor: 3.090

6.  Dilution testing using rapid diagnostic tests in a HIV diagnostic algorithm: a novel alternative for confirmation testing in resource limited settings.

Authors:  Leslie Shanks; M Ruby Siddiqui; Almaz Abebe; Erwan Piriou; Neil Pearce; Cono Ariti; Johnson Masiga; Libsework Muluneh; Joseph Wazome; Koert Ritmeijer; Derryck Klarkowski
Journal:  Virol J       Date:  2015-05-14       Impact factor: 4.099

7.  Development of a proficiency testing program for the HIV-1 BED incidence assay in China.

Authors:  Hao Yan; Haiying Yu; Wenge Xing; Yao Xiao; Hui Zhang; Lijian Pei; Na Zhang; Yan Jiang
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

Review 8.  Peptides to combat viral infectious diseases.

Authors:  Shams Al-Azzam; Yun Ding; Jinsha Liu; Priyanka Pandya; Joey Paolo Ting; Sepideh Afshar
Journal:  Peptides       Date:  2020-09-01       Impact factor: 3.750

9.  Initial Accuracy of HIV Rapid Test Kits Stored in Suboptimal Conditions and Validity of Delayed Reading of Oral Fluid Tests.

Authors:  Augustine T Choko; Miriam Taegtmeyer; Peter MacPherson; Derek Cocker; McEwen Khundi; Deus Thindwa; Rodrick S Sambakunsi; Moses K Kumwenda; Kondwani Chiumya; Owen Malema; Simon D Makombe; Emily L Webb; Elizabeth L Corbett
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection.

Authors:  Joseph B Margolick; Linda Apuzzo; Joel Singer; Hubert Wong; Terry Lee; Joel E Gallant; Phillippe El-Helou; Mona R Loutfy; Anita Rachlis; Christopher Fraser; Kenneth Kasper; Cécile Tremblay; Harout Tossonian; Brian Conway
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.